Cronos Group Reports 2021 Third Quarter Results Completed Audit Committee evaluation and restated Q2 2021 unaudited interim financial statements Announces strategic realignment to support future growth strategies Consolidated net...
Cronos Group Files Form 12b-25 TORONTO, Nov. 09, 2021 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that it has...
Cronos Group Reports 2021 Second Quarter Results Amended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids Announced strategic investment in PharmaCann, a leading U.S. cannabis company Spinach™...
Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market PharmaCann...
Cronos Group Reports 2021 First Quarter Results Receives processing license for the commercial production and sale of cannabinoids using biosynthesis Announces plans to launch Spinach™ branded edibles to the...
Cronos Group Reports 2020 Fourth Quarter and Full-Year Results Announces plans to launch Happy Dance™ in ULTA Beauty™ Cronos Israel continues to grow the PEACE NATURALS™ brand in the...
The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$10 million per...
Cronos Group Reports 2020 Third Quarter Results Kurt Schmidt appointed President and CEO; Mike Gorenstein appointed Executive Chairman Launched a new hemp-derived CBD brand, Happy Dance™, in the U.S....
Cronos Group Announces Expanded Leadership Structure to Drive Next Phase of Growth 30-Year CPG Executive Kurt Schmidt Joins Cronos as Chief Executive Officer and Mike Gorenstein Named Executive Chairman...
Cronos Group Reports 2020 First Quarter Results Fermented target cannabinoid, CBGA, using cannabinoid strains at Cronos Fermentation R&D labs Successfully completed first dried flower shipment to Israel, as Cronos...
Cronos Group Reports 2019 Fourth Quarter and Full-Year Results Completed Audit Committee Review and Restated Certain 2019 Unaudited Interim Financial Statements Expanded Canadian distribution to new provinces and product...
Cronos Group Inc. Announces First Quarter 2019 Results Cronos Group Closes C$2.4 Billion Strategic Investment from Altria Group Cronos Group Establishes Cronos Device Labs, a State-of-the-Art Vaporizer R&D Initiative...
Cronos Group Opens Cronos Device Labs, New Global R&D Center in Israel Accelerates Efforts to Develop Next-Generation Vaporizer Products Designed Specifically for Cannabinoids TORONTO, May 07, 2019 (GLOBE NEWSWIRE)...
Cronos Group Inc. Announces Fourth Quarter 2018 and Full Year 2018 Results Closed C$2.4 Billion Strategic Growth Investment from Altria Group, Inc. Completed first harvest in Peace Naturals expansion...
Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc. Four New Directors Join Cronos Group Board Jerry Barbato Appointed Chief Financial Officer of Cronos Group;...
Cronos Group Inc. Announces C$2.4 Billion Strategic Investment from Altria Group, Inc. TORONTO, Dec. 7, 2018 /PRNewswire/ – Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that...
Cronos Group Inc. Announces Third Quarter 2018 Results Increased Revenues 186% and Kilograms Sold 213% Year-over-Year Licensed and Commenced Cultivation in Building 4 Announced Landmark Partnership with Ginkgo Bioworks...
TORONTO, Sept. 13, 2018 /PRNewswire/ – Today, Cronos Group Inc. (“Cronos Group” or the “Company”) is pleased to announce the launch of its second cannabis brand for the domestic recreational...
